Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis. Issue 6 (11th September 2013)
- Record Type:
- Journal Article
- Title:
- Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis. Issue 6 (11th September 2013)
- Main Title:
- Genetic inactivation of Nupr1 acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis
- Authors:
- Cano, Carla E
Hamidi, Tewfik
Garcia, Maria Noé
Grasso, Daniel
Loncle, Céline
Garcia, Stéphane
Calvo, Ezequiel
Lomberk, Gwen
Dusetti, Nelson
Bartholin, Laurent
Urrutia, Raul
Iovanna, Juan L - Abstract:
- Abstract : Background: Nuclear protein 1 (Nupr1) is a major factor in the cell stress response required for Kras G12D -driven formation of pancreatic intraepithelial neoplastic lesions (PanINs). We evaluated the relevance of Nupr1 in the development of pancreatic cancer. Methods: We investigated the role of Nupr1 in pancreatic ductal adenocarcinoma (PDAC) progression beyond PanINs in Pdx1-cre;LSL-Kras G12D ;Ink4a/Arf fl/fl ( KIC ) mice. Results: Even in the context of the second tumorigenic hit of Ink4a/Arf deletion, Nupr1 deficiency led to suppression of malignant transformation involving caspase 3 activation in premalignant cells of KIC pancreas. Only half of Nupr1 -deficient; KIC mice achieved PDAC development, and incident cases survived longer than Nupr1 wt ;KIC mice. This was associated with the development of well-differentiated PDACs in Nupr1 -deficient; KIC mice, which displayed enrichment of genes characteristic of the recently identified human classical PDAC subtype. Nupr1 -deficient; KIC PDACs also shared with human classical PDACs the overexpression of the Kras-activation gene signature. In contrast, Nupr1 wt ;KIC mice developed invasive PDACs with enriched gene signature of human quasi-mesenchymal (QM) PDACs. Cells derived from Nupr1- deficient; KIC PDACs growth in an anchorage-independent manner in vitro had higher aldehyde dehydrogenase activity and overexpressed nanog, Oct-4 and Sox2 transcripts compared with Nupr1 wt ;KIC cells. Moreover, Nupr1 -deficientAbstract : Background: Nuclear protein 1 (Nupr1) is a major factor in the cell stress response required for Kras G12D -driven formation of pancreatic intraepithelial neoplastic lesions (PanINs). We evaluated the relevance of Nupr1 in the development of pancreatic cancer. Methods: We investigated the role of Nupr1 in pancreatic ductal adenocarcinoma (PDAC) progression beyond PanINs in Pdx1-cre;LSL-Kras G12D ;Ink4a/Arf fl/fl ( KIC ) mice. Results: Even in the context of the second tumorigenic hit of Ink4a/Arf deletion, Nupr1 deficiency led to suppression of malignant transformation involving caspase 3 activation in premalignant cells of KIC pancreas. Only half of Nupr1 -deficient; KIC mice achieved PDAC development, and incident cases survived longer than Nupr1 wt ;KIC mice. This was associated with the development of well-differentiated PDACs in Nupr1 -deficient; KIC mice, which displayed enrichment of genes characteristic of the recently identified human classical PDAC subtype. Nupr1 -deficient; KIC PDACs also shared with human classical PDACs the overexpression of the Kras-activation gene signature. In contrast, Nupr1 wt ;KIC mice developed invasive PDACs with enriched gene signature of human quasi-mesenchymal (QM) PDACs. Cells derived from Nupr1- deficient; KIC PDACs growth in an anchorage-independent manner in vitro had higher aldehyde dehydrogenase activity and overexpressed nanog, Oct-4 and Sox2 transcripts compared with Nupr1 wt ;KIC cells. Moreover, Nupr1 -deficient and Nurpr1 wt ;KIC cells differed in their sensitivity to the nucleoside analogues Ly101-4b and WJQ63. Together, these findings show the pivotal role of Nupr1 in both the initiation and late stages of PDAC in vivo, with a potential impact on PDAC cell stemness. Conclusions: According to Nupr1 status, KIC mice develop tumours that phenocopy human classical or QM-PDAC, respectively, and present differential drug sensitivity, thus becoming attractive models for preclinical drug trials. … (more)
- Is Part Of:
- Gut. Volume 63:Issue 6(2014)
- Journal:
- Gut
- Issue:
- Volume 63:Issue 6(2014)
- Issue Display:
- Volume 63, Issue 6 (2014)
- Year:
- 2014
- Volume:
- 63
- Issue:
- 6
- Issue Sort Value:
- 2014-0063-0006-0000
- Page Start:
- 984
- Page End:
- 995
- Publication Date:
- 2013-09-11
- Subjects:
- PANCREAS -- ONCOGENES -- PANCREATIC CANCER -- STRESS -- CANCER
Gastroenterology -- Periodicals
616.33 - Journal URLs:
- http://gut.bmjjournals.com ↗
http://www.bmj.com/archive ↗ - DOI:
- 10.1136/gutjnl-2013-305221 ↗
- Languages:
- English
- ISSNs:
- 0017-5749
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 19840.xml